Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Morgan-Cooper

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
JAMA Network Open|November 6, 2025
Molecularly Targeted Cancer Medications and Kidney HealthSusan Ziolkowski, Jin Long, Yutong Zhong, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
The Role Of Drug Indication On Incidence Rate Heterogeneity: A Large-Scale, Systematic Evaluation Across An International Network Of Observational DatabasesHsin Yi Chen, Christopher Knoll, Elise Boventer, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Diabetes, Obesity & Metabolism|June 3, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Arthritis Care & Research|August 12, 2025
Identification of Adult Dermatomyositis Patients Using Real-World Data SourcesBenjamin Martin, Will Kelly, Hannah Morgan-Cooper, et al.
BMJ Open Diabetes Research & Care|November 5, 2025
Semaglutide and diabetic retinopathy: an OHDSI network studyCindy Xinji Cai, Akihiko Nishimura, Sally Baxter, et al.
Ophthalmology|June 2, 2026
Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network StudyCindy X Cai, Brian Toy, Benjamin Martin, et al.
JAMA Ophthalmology|February 20, 2025
Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyCindy X Cai, Michelle Hribar, Sally Baxter, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
JAMA Network Open|November 6, 2025
Molecularly Targeted Cancer Medications and Kidney HealthSusan Ziolkowski, Jin Long, Yutong Zhong, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
The Role Of Drug Indication On Incidence Rate Heterogeneity: A Large-Scale, Systematic Evaluation Across An International Network Of Observational DatabasesHsin Yi Chen, Christopher Knoll, Elise Boventer, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Diabetes, Obesity & Metabolism|June 3, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Arthritis Care & Research|August 12, 2025
Identification of Adult Dermatomyositis Patients Using Real-World Data SourcesBenjamin Martin, Will Kelly, Hannah Morgan-Cooper, et al.
BMJ Open Diabetes Research & Care|November 5, 2025
Semaglutide and diabetic retinopathy: an OHDSI network studyCindy Xinji Cai, Akihiko Nishimura, Sally Baxter, et al.
Ophthalmology|June 2, 2026
Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network StudyCindy X Cai, Brian Toy, Benjamin Martin, et al.
JAMA Ophthalmology|February 20, 2025
Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyCindy X Cai, Michelle Hribar, Sally Baxter, et al.
Pageof 1